About DMPL Pharmaceuticals Private Limited
Data last updated:
DMPL Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 October 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2016PTC286559. Its GSTIN is 27AAGCG5725K1ZB (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Genesun Pharma Private Limited. It is led by directors Sunny Kumar Prem Nath Upadhaya and Vikesh Premnath Upadhyay.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2020, the company reported a revenue of ₹18.9 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹13.12 Lakh (net margin -69.4%) and EBITDA of -₹13.11 Lakh (EBITDA margin -69.4%).
Court records list 4 cases involving the company, including 2 filed against it; 3 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dmplgroup.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No. X – 25/9 – 21 Gala No. 20 First Floor Gaondevi Shopping Center MIDC Dombivali, East, Thane, Maharashtra, India – 421203
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of DMPL Pharmaceuticals Private Limited
The main business activity of DMPL Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of DMPL Pharmaceuticals Private Limited FY 2020 filings available
DMPL Pharmaceuticals Private Limited reported revenue of ₹18.9 Lakh (up 432% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR) of DMPL Pharmaceuticals Private Limited
Revenue rose 432% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of DMPL Pharmaceuticals Private Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹18.9 Lakh | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | -₹13.11 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹13.12 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of DMPL Pharmaceuticals Private Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -69.4% | •••• | •••• | •••• |
| Net Profit Margin | -69.4% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of DMPL Pharmaceuticals are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of DMPL Pharmaceuticals Private Limited
DMPL Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikesh Premnath Upadhyay Also directs: Varren Maritime Academy Foundation, Varren Restro Fusion Private Limited, Varren Marines Shipping Private Limited and 2 more | Additional Director | 09 Jan 2017 | 9 Years 9 Months | Current |
| Sunny Kumar Prem Nath Upadhaya | Director | 05 Oct 2016 | 10 Years 0 Months | Current |
Peer Comparison of DMPL Pharmaceuticals Private Limited
DMPL Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Winystra Pharmaceuticals Private Limited | ₹18.97 Lakh (FY 2025) | •••• | •••• | 6.0% | •••• | Bangalore, Karnataka, India |
| Emrayaa Pharmaceuticals Private Limited | ₹18.97 Lakh (FY 2022) | •••• | •••• | •••• | Thane, Maharashtra, India | |
| Triple Twelve Pharmaceuticals Private Limited | ₹18.91 Lakh (FY 2025) | •••• | •••• | -32.0% | •••• | Kodungallur, Kerala, India |
| Maharaja Aggarsain Pharmaceuticals Private Limited | ₹18.91 Lakh (FY 2021) | •••• | •••• | 29.0% | •••• | Hansi, Haryana, India |
| Emuric Pharmaceuticals Private Limited | ₹18.9 Lakh (FY 2025) | •••• | •••• | -16.0% | •••• | Patna, Bihar, India |
| DMPL Pharmaceuticals Private Limited this company | ₹18.9 Lakh (FY 2020) | •••• | •••• | 432.0% | •••• | Thane, Maharashtra, India |
| Ajes Pharmaceuticals Private Limited | ₹18.87 Lakh (FY 2025) | •••• | •••• | -2.0% | •••• | Bhoapl, Madhya Pradesh, India |
| Siramed Pharmaceuticals (OPC) Private Limited | ₹18.85 Lakh (FY 2025) | •••• | •••• | 29.0% | •••• | Bangalore, Karnataka, India |
| Humakind Pharmaceuticals Private Limited | ₹18.78 Lakh (FY 2025) | •••• | •••• | 32.0% | •••• | Basti, Uttar Pradesh, India |
| Biolily Pharmaceuticals (OPC) Private Limited | ₹18.69 Lakh (FY 2025) | •••• | •••• | 38.0% | •••• | Varanasi, Uttar Pradesh, India |
| Kornique Pharmaceuticals Private Limited | ₹18.68 Lakh (FY 2024) | •••• | •••• | 219.0% | •••• | Kosikalan, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below DMPL Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of DMPL Pharmaceuticals Private Limited
DMPL Pharmaceuticals Private Limited is audited by K H GUPTA & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K H GUPTA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of DMPL Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of DMPL Pharmaceuticals Private Limited
DMPL Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of DMPL Pharmaceuticals Private Limited
DMPL Pharmaceuticals Private Limited has 4 court cases on record: 2 filed against it, 2 where it is another party. 3 cases are pending and 1 is disposed. Status as checked between 01 Oct 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 2 | 3 |
Cases on record (3 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Court case (R.C.C.) | Company is another party | Pending |
| District court, Thane, Maharashtra | Court case (R.C.C.) | Filed against the company by Rajshri Deepak Shinde , Drug Inspector, State of Maharashtra | Pending |
| District court, Thane, Maharashtra | Court case (R.C.C.) | Company is another party | Disposed |
Full case history
All 4 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at DMPL Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to DMPL Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on DMPL Pharmaceuticals Private Limited
DMPL Pharmaceuticals Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Chandrabhushan Rambharose Pande ceased to be Director on 24 May 2018.
Credit Ratings, Litigation & Regulatory Alerts for DMPL Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by DMPL Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of DMPL Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of DMPL Pharmaceuticals Private Limited
DMPL Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCG5725K1ZB | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of DMPL Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DMPL Pharmaceuticals Private Limited
DMPL Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 October 2016 (10+ years old) and is registered under CIN U74999MH2016PTC286559.
DMPL Pharmaceuticals reported revenue of ₹18.9 Lakh for FY 2020 (up 432% YoY).
DMPL Pharmaceuticals has 2 current directors:
- Vikesh Premnath Upadhyay - Additional Director
- Sunny Kumar Prem Nath Upadhaya - Director
DMPL Pharmaceuticals reported a net loss of ₹13.12 Lakh (net margin -69.4%) and EBITDA of -₹13.11 Lakh (EBITDA margin -69.4%) for FY 2020, as per its filed financial statements.
The GSTIN of DMPL Pharmaceuticals is 27AAGCG5725K1ZB, registered in Maharashtra.
The CIN (Corporate Identification Number) of DMPL Pharmaceuticals is U74999MH2016PTC286559. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
DMPL Pharmaceuticals has 4 court cases on record: 2 filed against it. 3 are pending.
DMPL Pharmaceuticals was incorporated on 05 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of DMPL Pharmaceuticals by revenue are Winystra Pharmaceuticals Private Limited, Emrayaa Pharmaceuticals Private Limited, Triple Twelve Pharmaceuticals Private Limited, Maharaja Aggarsain Pharmaceuticals Private Limited, Emuric Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Chandrabhushan Rambharose Pande ceased to be Director on 24 May 2018. Rangnayaki Sunny Upadhyay ceased to be Managing Director on 05 Feb 2018. Vikesh Premnath Upadhyay was appointed as Additional Director on 09 Jan 2017. DMPL Pharmaceuticals has 4 board changes on record in total.
DMPL Pharmaceuticals can be reached through the website dmplgroup.com. Its registered office is in Thane, Maharashtra, India.